LLY - ELI LILLY & Co


1076.98
5.340   0.496%

Share volume: 932,804
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.12%

PREVIOUS CLOSE
CHG
CHG%

$1,071.64
5.34
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 02-19-2025 04-30-2024 08-08-2024 10-30-2024 02-19-2025 05-01-2025 08-07-2025 10-30-2025
Total revenue 9.353 B 8.768 B 11.303 B 11.439 B 13.533 B 12.729 B 15.558 B 17.601 B
Cost of revenue 1.788 B 1.674 B 2.170 B 2.171 B 2.404 B 2.224 B 2.448 B 3.008 B
Gross profit 7.565 B 7.095 B 9.133 B 9.268 B 11.129 B 10.504 B 13.110 B 14.593 B
    -6.22% 28.73% 1.49% 20.08% -5.61% 24.81% 11.31%  
Operating expenses 5.110 B 4.586 B 4.983 B 7.660 B 5.636 B 6.774 B 6.243 B 6.862 B
Selling general and admin 1.925 B 1.952 B 2.117 B 2.100 B 2.425 B 2.469 B 2.753 B 2.741 B
Research and development 3.185 B 2.633 B 2.866 B 5.561 B 3.212 B 4.305 B 3.490 B 4.121 B
Total expenses 5.178 B 4.586 B 5.418 B 7.742 B 5.980 B 6.809 B 6.243 B 7.227 B
    -11.44% 18.15% 42.90% -22.76% 13.86% -8.32% 15.76%  
Operating income 2.388 B 2.509 B 3.715 B 1.526 B 5.149 B 3.695 B 6.867 B 7.366 B
Ebit 2.509 B 2.536 B 3.517 B 1.588 B 5.039 B 3.456 B 6.776 B 7.232 B
Pretax income 2.509 B 2.536 B 3.517 B 1.588 B 5.039 B 3.456 B 6.776 B 7.232 B
    1.09% 38.69% -54.84% 217.22% -31.41% 96.07% 6.73%  
Income tax 319.100 M 293.200 M 550.200 M 618.100 M 628.900 M 696.800 M 1.116 B 1.650 B
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 2.190 B 2.243 B 2.967 B 970.300 M 4.410 B 2.759 B 5.661 B 5.583 B
    2.43% 32.28% -67.30% 354.48% -37.43% 105.14% -1.38%